Nanocapsule formation by cyclodextrins

Nanoencapsulation Technologies for the Food and Nutraceutical Industries

Volumn , Issue , 2017, Pages 187-261

  Gharibzahedi, Seyed M T ^a   Jafari, Seid Mahdi ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b GORGAN UNIVERSITY OF AGRICULTURAL SCIENCES AND NATURAL RESOURCES   (Iran)

Author keywords

Cyclodextrin; Inclusion complex; Nanocarrier; Nanoencapsulation; Nutraceutical delivery

Indexed keywords

CHEMICAL MODIFICATION; NANOCAPSULES; NANOPARTICLES; SURFACE ACTIVE AGENTS;

CYCLIC OLIGOSACCHARIDES; INCLUSION COMPLEX; NANO-ENCAPSULATION; NANOCARRIERS; NANOPARTICULATE SYSTEM; NUTRACEUTICALS; POLYMERIC NANOPARTICLES; SUPRAMOLECULAR STRUCTURE;

CYCLODEXTRINS;

EID: 85042728709     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-809436-5.00007-0     Document Type: Chapter

References (332)

1. Abdelwahed W., Degobert G., Dubes A., Parrot-Lopez H., Fessi H. Sulfated and non-sulfated amphiphilic-beta-cyclodextrins: impact of their structural properties on the physicochemical properties of nanoparticles. Int. J. Pharm. 2008, 351:289-295.
2. Abou-Taleb A.E., Abdel-Rhman A.A., Samy E.M., Tawfeek H.M. Interaction of rofecoxib with β-cyclodextrin and HP-β-cyclodextrin in aquoues solution and in solid state. Bull. Pharm. Sci. Assiut Univ. 2006, 29:236-252.
3. Abu Mukh-Qasem R., Gedanken A. Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles. J. Colloid Interface Sci. 2005, 284:489-494.
4. Aftabrouchard D., Dorlker E. Preparation methods for biodegradable microparticles loaded with water-soluble drugs. STP Pharma. Sci. 1992, 2:365-380.
5. Agüeros M., Zabaleta V., Espuelas S., Campanero M.A., Irache J.M. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J. Control. Release 2010, 145:2-8.
6. Ahmd M., Rashid K., Nadeem M., Masood K., Ali S., Nafees M., Gull N., Mumtaz-ul-Haq, Ibrahim N., Saeed A., Qureshy A., Aleem F., Naseer H., Mehmood S., Hyder S.W. A simple method to prepare aqueous dispersion of iron oxide nanoparticles and their biodistribution study. J. Colloid Sci. Biotechnol. 2012, 1:201-209.
7. Ahsan A., Aziz A., Arshad M.A., Ali O., Nauman M., Ahmad N.M., Elaissari A. Smart magnetically engineering colloids and biothin films for diagnostics applications. J. Colloid Sci. Biotechnol. 2013, 2:19-26.
8. Alamdarnejad G., Sharif A., Taranejoo S., Janmaleki M., Kalaee M.R., Dadgar M., Khakpour M. Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole. J. Mater. Sci. Mater. Med. 2013, 24:1939-1949.
9. Al-Marzouqi A.H., Jobe B., Dowaidar A., Maestrelli F., Mura P. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes; comparison with conventional methods. J. Pharm. Biomed. Anal. 2007, 43:566-574.
10. Al-Marzouqi A.H., Elwy H.M., Shehadi I., Adem A. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J. Pharm. Biomed. Anal. 2009, 49:227-233.
11. Anirudhan T., Dilu D., Sandeep S. Synthesis and characterisation of chitosan crosslinked-β-cyclodextrin grafted silylated magnetic nanoparticles for controlled release of indomethacin. J. Magn. Magn. Mater. 2013, 343:149-156.
12. Ascenso A., Guedes R., Bernardino R., Diogo H., Carvalho F.A., Santos N.C., Silva A.M., Marques H.C. Complexation and full characterization of the tretinoin and dimethyl-β-cyclodextrin complex. AAPS Pharm. Sci. Tech. 2011, 12:553-563.
13. Asp M.L., Hertzler S.R., Chow J., Wolf B.W. Gamma-cyclodextrin lowers postprandial glycemia and insulinemia without carbohydrate malabsorption in healthy adults. J. Am. Coll. Nutr. 2006, 25:49-55.
14. Astray G., Gonzalez-Barreiro C., Mejuto J.C., Rial-Otero R., Simal-Gándara J. A review on the use of cyclodextrins in foods. Food Hydrocolloid. 2009, 23:1631-1640.
15. Augustin M.A., Hemar Y. Nano- and micro-structured assemblies for encapsulation of food ingredients. Chem. Soc. Rev. 2009, 38:902-912.
16. Badruddoza A.Z.M., Rahman M.T., Ghosh S., Hossain M.Z., Shi J., Hidajat K., Uddin M.S. β-cyclodextrin conjugated magnetic, fluorescent silica core-shell nanoparticles for biomedical applications. Carbohydr. Polym. 2013, 95:449-457.
17. Banerjee S.S., Chen D.H. Magnetic nanoparticles grafted with cyclodextrin for hydrophobic drug delivery. Chem. Mater. 2007, 19:6345-6349.
18. Bardajee G.R., Vancaeyzeele C., Haley J.C., Li A.Y., Winnik M.A. Synthesis, characterization, and energy transfer studies of dye-labeled poly(butylmethacrylate) latex particles prepared by miniemulsion polymerization. Polymer 2007, 48:5839-5849.
19. Baruch-Sharon S., Margel S. Synthesis and characterization of poly-chloromethylstyrene nanoparticles of narrow size distribution by emulsion and miniemulsion polymerization processes. Colloid. Polym. Sci. 2010, 288:869-877.
20. Baruch-Teblum E., Mastai Y., Landfester K. Miniemulsion polymerization ofcyclodextrin nanospheres for water purification from organic pollutants. Eur. Polym. J. 2010, 46:1671-1678.
21. Bellanger N., Perly B. NMR investigations of the conformation of new cyclodextrins- based amphiphilic transporters for hydrophobic drugs: Molecular lollipops. J. Mol. Struct. 1992, 15:215-226.
22. Bertrand P., Jonas A., Laschevsky A., Legras R. Ultrathin polymer coating by complexation of polyelectrolytes. Macromol. Rapid Commun. 2000, 21:319-348.
23. Bhandari B.R., D'Arcy B.R., Padukka I. Encapsulation of lemon oil by paste method using β-cyclodextrin. J. Agric. Food Chem. 1999, 47:5194-5197.
24. Bhati L.K., Tiwari G., Tiwari R., Kumar V. Enhancement of complexation efficiency of meloxicam using binary and ternary solid systems: formulation considerations. Am. J. Drug Discov. Dev. 2012, 2:17-31.
25. Bilensoy E., Hincal A.A. Cyclodextrin-based nanomaterials in pharmaceutical field. Pharmaceutical Manufacturing Handbook: Production and Processes 2008, 1225-1247. John Wiley & Sons, NJ, USA. S.C. Gad (Ed.).
26. Bilensoy E., Hincal A.A. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert Opin. Drug Deliv. 2009, 6:1161-1173.
27. Bilensoy E., Gürkaynak O., Doğan A.L., Hincal A.A. Safety and efficacy of amphiphilic β-cyclodextrin nanoparticles for paclitaxel delivery. Int. J. Pharm. 2008, 347:163-170.
28. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev. 1995, 24:19-33.
29. Borghetti G.S., Lula I.S., Sinisterra R.D., Bassani V.L. Quercetin/β-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture. AAPS Pharm. Sci. Tech. 2009, 10:235-242.
30. Bouchemal K., Briançon S., Perrier E., Fessi H., Bonnet I., Zydowicz N. Synthesis and characterization of polyurethane and poly (ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. Int. J. Pharm. 2004, 269:89-100.
31. Bouchemal K., Briançon S., Fessi H., Chevalier Y., Bonnet I., Perrier E. Simultaneous emulsification and interfacial polycondensation for the preparation of colloidal suspension of nanocapsules. Mater. Sci. Eng. C 2006, 26:472-480.
32. Bouchemal K., Couenne F., Briançon S., Fessi H., Tayakout M. Polyamides nanocapsules: modelling and wall thickness estimation. AIChE J. 2006, 52:1-10.
33. Boudad H., Legrand P., Lebas G., Cheron M., Duchêne D., Ponchel G. Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate)nanoparticles intended for oral administration of saquinavir. Int. J. Pharm. 2001, 218:113-124.
34. Buschmann H.J., Schollmeyer E. Applications of cyclodextrins in cosmetic products: a review. J. Cosmet. Sci. 2002, 53:185-191.
35. Cabral Marques H.M. A review on cyclodextrin encapsulation of essential oils and volatiles. Flavour Fragr. J. 2010, 25:313-326.
36. Canceill J., Jullien L., Lacombe L., Lehn J.M. Channel type molecular structures, Part 2, synthesis of bouquet-shaped molecules based on a β-cyclodextrin core. Helv. Chim. Acta 1992, 75:791-812.
37. Cao F.T., Guo J., Ping Q. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes. Drug Dev. Ind. Pharm. 2005, 31:747-756.
38. Cao H.N., He J., Deng L., Gao X.Q. Fabrication of cyclodextrin-functionalized superparamagnetic Fe3O4/amino-silane core-shell nanoparticles via layer-by-layer method. Appl. Surf. Sci. 2009, 255:7974-7980.
39. Charcosset C., Fessi H. Amembrane contactor for the preparation of nanoparticles. Desalination 2006, 200:568-569.
40. Charoenchaitrakool M., Dehghani F., Foster N.R. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl- betacyclodextrin. Int. J. Pharm. 2009, 239:103-112.
41. Chaudhary A., Nagaich U., Gulati N., Sharma V.K., Khosa R.L. Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: A recent review. J. Adv. Pharm. Edu. Res. 2012, 2:32-67.
42. Chelli S., Majdoub M., Aeiyach S., Jouini M. Polyrotaxanes basedon polyethers and β-cyclodextrin. J. Polym. Sci. Polym. Chem. 2009, 47:4391-4399.
43. Chen D., Xu R. Hydrothermal synthesis and characterization of nanocrystalline Fe3O4 powders. Mater. Res. Bull. 1998, 33:1015-1021.
44. Choi H.G., Lee B.J., Han J.H., Lee M.K., Park K.M., Yong C.S., Rhee J.D., Kim Y.B., Kim C.K. Terfenadine-β-cyclodextrin inclusion complex with antihistaminic activity enhancement. Drug Dev. Ind. Pharm. 2001, 27:857-862.
45. Choi M.J., Hong G.P., Briancon S., Fessi H., Lee M.Y., Min S.G. Effect of a high-pressure-induced freezing process on the stability of freeze-dried nanocapsules. Drying Technol. 2008, 26:1199-1207.
46. Choi M.J., Ruktanonchai U., Min S.G., Chun J.Y., Soottitantawat A. Physical characteristics of fish oil encapsulated by β-cyclodextrin using an aggregation method or polycaprolactone using an emulsion-diffusion method. Food Chem. 2010, 119:1694-1703.
47. Choisnard L., Géze A., Bigan M., Putaux J.L., Wouessidjewe D. Efficient size control of amphiphilic cyclodextrin nanoparticles through a statistical mixture design methodology. J. Pharm. Pharm. Sci. 2005, 8:593-600.
48. Choisnard L., Gèze A., Putaux J.L., Wong Y.S., Wouessidjewe D. Nanoparticles of β-cyclodextrin esters obtained by self-assembling of biotransesterified β-cyclodextrins. Biomacromol. 2006, 7:515-520.
49. Choisnard L., Gèze A., Yaméogo B.G., Putaux J.L., Wouessidjewe D. Miscellaneous nanoaggregates made of β-CD esters synthesised by an enzymatic pathway. Int. J. Pharm. 2007, 344:26-32.
50. Chronopoulou L., Fratoddi I., Palocci C., Venditti I., Russo M.V. Osmosis based method drives the self-assembly of polymeric chains into micro and nanostructures. Langmuir 2009, 25:119406.
51. Ciobanu A., Landy D., Fourmentin S. Complexation efficiency of cyclodextrins for volatile flavor compounds. Food Res. Int. 2013, 53:110-114.
52. Çirpanli Y., Bilensoy E., Lale Doğan A., Calis S. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur. J. Pharm. Biopharm. 2009, 73:82-89.
53. Cirri M., Maestrelli F., Mennini N., Mura P. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems. J. Pharm. Biomed. Anal. 2009, 50:690-694.
54. Cirri M., Bragagni M., Mennini N., Mura P. Development of a new delivery system consisting in 'drug-in cyclodextrin-in nanostructured lipid carriers' for ketoprofen topical delivery. Eur. J. Pharm. Biopharm. 2012, 80:46-55.
55. Cravotto G., Binello A., Baranelli E., Carraro P., Trotta F. Cyclodextrins as food additives and in food processing. Curr. Nutr. Food Sci. 2006, 2:343-350.
56. Crespy D., Landfester K. Synthesis of polyvinylpyrrolidone/silver nanoparticles hybrid latex in non-aqueous miniemulsion at high temperature. Polymer 2009, 50:1616-1620.
57. Crespy D., Stark M., Hoffmann-Richter C., Ziener U., Landfester K. Polymeric nanoreactors for hydrophilic reagents synthesized by interfacial polycondensation on miniemulsion droplets. Macromolecules 2007, 40:3122-3135.
58. Crini G. Review: a history of cyclodextrins. Chem. Rev. 2014, 114:10940-10975.
59. Cryan S.A., Donohue R., Ravo B.J., Darcy R., O'Driscoll C.M. Cationic cyclodextrin amphiphiles as gene delivery vectors. J. Drug Del. Sci. Technol. 2004, 14:57-62.
60. Cryan S.A., Holohan A., Donohue R., Darcy R., O'Driscoll C.M. Cell transfection with polycationic cyclodextrin vectors. Eur. J. Pharm. Sci. 2004, 21:625-633.
61. Csabai K., Vikmon M., Szejtli J., Redenti E., Poli G., Ventura P. Complexation of manidipine with cyclodextrins and their derivatives. J. Incl. Phenom. Mol. Recognit. Chem. 1998, 31:169-178.
62. da Costa G.M., Grave E.D., de Bakker P.M.A., Vandenberghe R.E. Synthesis and characterization of some iron oxides by sol-gel method. J. Solid State Chem. 1994, 113:405-412.
63. Danicher L., Frere Y., Calve A.L. Synthesis by interfacial polycondensation of polyamide capsules with various sizes. Charecteristics and properties. Macromol. Symp. 2000, 151:387-392.
64. Das S.K., Rajabalaya R., David S., Gani N., Khanam J., Nanda A. Cyclodextrins-the molecular container Res. J. Pharmaceut. Biol. Chem. Sci. 2013, 4:1694-1720.
65. De Cock L.J., De Koker S., De Geest B.G., Grooten J., Vervaet C., Remon J.P., Sukhorukov G.B., Antipina M.N. Polymeric multilayer capsules in drug delivery. Angew. Chem. Int. Ed. 2010, 49:6954-6973.
66. De Jaeghere F., Doelker E., Gurny R. Nanoparticles. Encyclopedia of Controlled Drug Delivery 1999, 641-664. John Wiley & Sons, Inc, New York. E. Mathiowitz (Ed.).
67. Dehnad D., Jafari S.M., Afrasiabi M. Influence of drying on functional properties of food biopolymers: From traditional to novel dehydration techniques. Trends Food Sci. Tech. 2016, 57(Part A):116-131.
68. Del Valle E.M.M. Cyclodextrins and their uses: a review. Process Biochem. 2004, 39:1033-1046.
69. Deng Y., Wang L., Yang W., Fu S., Elassari A. Preparation of magnetic polymeric particles via inverse microemulsion polymerization process. J. Magn. Magn. Mater. 2003, 257:69-78.
70. Deshmukh S.S., Potnis V.V., Shelar D.B., Mahaparale P.R. Studies on inclusion complexes of ziprasidone hydrochloride with beta-cyclodextrin and hydroxypropyl beta-cyclodextrin. Indian Drug. 2007, 44:677-682.
71. Devil N.K.D., Rani A.P., Muneer J.M., Kumar K.S., Kaushik J., Sowjanya V. Cyclodextrins in pharmacy-an overview. Pharmacophore 2010, 1:155-165.
72. Dodziuk H., Chmurski K., Jurczak J., Koźmiński W., Lukin O., Sitkowski J., Stefaniak L. A dynamic NMR study of self-inclusion of a pendant group in amphiphilic 6-thiophenyl-6-deoxycyclodextrins. J. Mol. Struct. 2000, 519:33-36.
73. Doijad R.C., Kanakal M.M., Manvi I.V. Studies on piroxicam-beta-cyclodextrin inclusion complexes. Indian Pharma. VI 2007, 94-98.
74. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90:889-905.
75. Dubes A., Bouchu D., Lamartine R., Parrot-Lopez H. An efficient regiospecific synthetic route to multiply substituted acyl-sulphated β-cyclodextrins. Tetrahedron Lett. 2001, 42:9147-9151.
76. Dubes A., Degobert G., Fessi H., Parrot-Lopez H. Synthesis and characterisation of sulfated amphiphilic alpha-, beta- and gamma-cyclodextrins: application to the complexation of acyclovir. Carbohydr. Res. 2003, 338:2185-2193.
77. Duchêne D. Cyclodextrins and their inclusion complexes. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications 2011, Wiley, NJ, USA. E. Bilensoy (Ed.).
78. Duchêne D., Ponchel G., Wouessidjewe D. Cyclodextrins in targeting. Application to nanoparticles. Adv. Drug Deliv. Rev. 1999, 36:29-40.
79. El-Aasser, M.S., Ugelstad, J., Vanderhoff, J.W., 1979. Polymer Emulsification Process. US4177177 A.
80. Ethirajan A., Ziener U., Landfester K. Surface-functionalized polymeric nanoparticles as templates for biomimetic mineralization of hydroxyapatite. Chem. Mater. 2009, 21:2218-2225.
81. Fages J., Lochard H., Letourneau J.J., Sauceau M., Rodier E. Phase behavioral effects on particle formation processes using supercritical fluids. Powder Technol. 2004, 141:219-226.
82. Fan W., Yan W., Xu Z., Ni H. Formation mechanism of monodisperse, lowmolecular weight chitosan nanoparticles by ionic gelation technique. Colloid. Surf. B Biointerfaces 2012, 90:21-27.
83. Fang Z., Bhandari B. Encapsulation of polyphenols-a review. Trend. Food Sci. Technol. 2010, 21:510-523.
84. Faridi Esfanjani A., Jafari S.M. Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds. Colloids Surf. B. 2016, 146:532-543.
85. Fathi M., Martín A., McClements D.J. Nanoencapsulation of food ingredients using carbohydrate based delivery systems. Trend. Food Sci. Technol. 2014, 39:18-39.
86. Fenyvesi é., Vikmon M.A., Szente L. Cyclodextrins in food technology and human nutrition: benefits and limitations in 2012. Crit. Rev. Food Sci. Nutr. 2015, 56(12):1981-2004.
87. Fessi, H., Puissieux, F., Devissaguet, J.P., Thies, C., 1988. Process for the preparation of dispersible colloidal systems of a substance in the form of nanospheres. US Patent No. 5,118,528.
88. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial deposition following solvent displacement. Int. J. Pharm. 1989, 55:R1-R4.
89. Fessi, H.C., Devissaguet, J.P., Puisieux, F., Thies, C., 1997. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent 5,118,528.
90. Figueiras A., Carvalho R.A., Ribeiro L., Torres-Labandeira J.J., Veiga F.J.B. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur. J. Pharm. Biopharm. 2007, 67:531-539.
91. Freitas M.N., Marchetti J.M. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inammatory diseases. Int. J. Pharm. 2005, 295:201-211.
92. French D., Knapp D.W., Pazur H. Studies of the Schardinger dextrins. VI. The molecular size and structure of γ-dextrin. J. Am. Chem. Soc. 1950, 72:5120-5152.
93. Fresta M., Fontana G., Bucolo C., Cavallaro G., Giammona G., Puglisi G. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J. Pharm. Sci. 2001, 90:288-297.
94. Friedrich H., Nada A., Bodmier R. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophillic carriers. Drug Dev. Ind. Pharm. 2005, 31:719-728.
95. Furue M., Harada A., Nozakura S. Preparation of cyclodextrin-containing polymers and their catalysis in ester-hydrolysis. J. Polym. Sci., Polym. Lett. Ed. 1975, 13:357-360.
96. Furuta T., Yoshii H. Powdery encapsulation of d-limonene by kneading with mixed powders of β-cyclodextrin and maltodextrin at low water content. Biosci. Biotechol. Biochem. 1994, 58:847-850.
97. Furuta T., Yoshii H., Miyamoto A., Yasunishi A., Hirano H. Effects of water of inclusion complexes of d-limonene and cyclodextrins. Supramol. Chem. 1993, 1:321-325.
98. Ganachaud F., Katz J.L. Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and highshear devices. Chem. Phys. Chem. 2005, 6:209-216.
99. Gasco M., Trotta M. Nanoparticles from microemulsions. Int. J. Pharm. 1986, 29:267-268.
100. Gaudin F., Zydowicz N.S. Core-shell biocompatible polyurethane nanocapsules obtained by interfacial step polymerisation in miniemulsion. Colloid. Surf A 2008, 331:133-142.
101. Gèze A., Aous S., Baussanne I., Putaux J.-L., Defaye J., Wouessidjewe D. Influence of chemical structure of amphiphilic β-cyclodextrins on their ability to form stable nanoparticles. Int. J. Pharm. 2002, 242:301-305.
102. Gèze A., Tieu Chau L., Choisnard L., Mathieu J.P., Marti-Batlle D., Riou L., Putaux J.L., Wouessidjewe D. Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres. Int. J. Pharm. 2007, 344:135-142.
103. Gèze A., Choisnard L., Putaux J.L., Wouessidjewe D. Colloidal systems made of biotransesterified alpha, beta and gamma cyclodextrins grafted with C10 alkyl chains. Mater. Sci. Eng. C 2009, 29:458-462.
104. Gharibzahedi S.M.T., Razavi S.H., Mousavi S.M. Characterizing the natural canthaxanthin/2-hydroxypropyl-β-cyclodextrin inclusion complex. Carbohydr. Polym. 2014, 101:1147-1153.
105. Gharibzahedi S.M.T., Razavi S.H., Mousavi S.M. Optimal development of a new stable nutraceutical nanoemulsion based on the inclusion complex of 2-hydroxypropyl-β-cyclodextrin with canthaxanthin accumulated by Dietzia natronolimnaea HS-1 using ultrasound-assisted emulsification. J. Disp. Sci. Technol. 2015, 36:614-625.
106. Giordano F., Novak C., Moyano J.R. Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim. Acta 2001, 380:123-151.
107. Giri T.K., Choudhary C., Ajazuddin, Alexander A., Badwaik H., Tripathi D.K. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm. J. 2013, 21:125-141.
108. Guo Y., Guo S., Ren J., Zhai Y., Dong S., Wang E. Cyclodextrin functionalized graphene nanosheets with high supramolecular recognition capability: synthesis and host-guest inclusion for enhanced electrochemical performance. ACS Nano 2010, 4:4001-4010.
109. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
110. Ham H.T., Choi Y.S., Chee M.G., Chung I.J. Single wall carbon nanotubes covered with polystyrene nanoparticles by in-situ miniemulsion polymerization. J. Polym. Sci. Part A Polym. Chem. 2006, 44:573-584.
111. Hans M.L., Lowman A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 2002, 6:319-327.
112. He S., Shia W., Zhang X., Li J., Huang Y. β-cyclodextrins-based inclusion complexes of CoFe2O4 magnetic nanoparticles as catalyst for the luminol chemiluminescence system and their applications in hydrogen peroxide detection. Talanta 2010, 82:377-383.
113. Hedges A.R. Industrial applications of cyclodextrins. Chem. Rev. 1998, 98:2035-2044.
114. Hedges A. Cyclodextrins: properties and applications. Starch Chemistry and Technology 2009, 833-852. Academic Press, New York, USA. J. BeMiller, R. Whistler (Eds.).
115. Heo D.N., Yang D.H., Moon H.J., Lee J.B., Bae M.S., Lee S.C., Lee W.J., Sun I.C., Kwon I.K. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012, 33:856-866.
116. Higashi K., Tozuka Y., Moribe K., Yamamoto K. Salicylic acid/β-cyclodextrin 2:1 and 4:1 complex formation by sealed-heating method. J. Pharm. Sci. 2010, 99:4192-4200.
117. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 1965, 4:117-122.
118. Hornig S., Heinze T. Nanoscale structures of dextran esters. Carbohydr. Polym. 2007, 68:280-286.
119. Ieva E., Trapani A., Cioffi N., Ditaranto N., Monopoli A., Sabbatini L. Analytical characterization of chitosan nanoparticles for peptide drug delivery applications. Anal. Bioanal. Chem. 2009, 393:207-215.
120. Irie T., Uekama K. Pharmaceutical applications of cyclodextrins: III. Toxicological issues and safety evaluation. J. Pharm. Sci. 1997, 86:147-162.
121. Jafari S.M., He Y., Bhandari B. Encapsulation of nanoparticles of d-limonene by spray drying: role of emulsifiers and emulsifying techniques. Dry. Technol. 2007, 25:1069-1079.
122. Jafari S.M., Assadpoor E., Bhandari B., He Y. Nano-particle encapsulation of fish oil by spray drying. Food Res. Int. 2008, 41:172-183.
123. Jambhekar S., Casella R., Maher T. The physicochemical characteristics and bioavailability of indomethacin from β-cyclodextrin, hydroxyethyl-β-cyclodextrin, and hydroxypropyl-β-cyclodextrin complexes. Int. J. Pharm. 2004, 270:149-166.
124. JECFA, 2013. Codex Alimentarius gamma-cyclodextrin. Available from: . http://www.fao.org/fao-who-codexalimentarius/sh-proxy/ar/?lnk=1%26url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCAC%2BMISC%2B6-2015%252FCXA_006efs.pdf.
125. Jeon H.J., Jeong Y.I., Jang M.K., Park Y.H., Nah J.W. Effect of solvent on the preparation of surfactant free poly(dl-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int. J. Pharm. 2000, 207:99-108.
126. Jiang W., Yang H.C., Yang S.Y., Horng H.E., Hung J.C., Chen Y.C., Hong C.Y. Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J. Magn. Magn. Mater. 2004, 283:210-214.
127. Jiang X., Dausend J., Hafner M., Musyanovych A., Röcker C., Landfester K., Mailan-der V., Nienhaus G.U. Specific effects of surface amines on polystyrenenanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules 2010, 11:748-753.
128. Kalogeropoulos N., Yannakopoulou K., Gioxari A., Chiou A., Makris P.D. Polyphenol characterization and encapsulation in β-cyclodextrin of a flavonoid-rich Hypericum perforatum (St John's wort) extract. LWT-Food Sci. Technol. 2010, 43:882-889.
129. Kang Y., Zhou L., Lib X., Yuan J. β-cyclodextrin-modified hybrid magnetic nanoparticles for catalysis and adsorption. J. Mater. Chem. 2011, 21:3704-3710.
130. Karathanos V.T., Mourtzinos I., Yannakopoulou K., Andrikopoulos N.K. Study of the solubility, antioxidant activity, and structure of inclusion complex of vanillin with beta-cyclodextrin. Food Chem. 2007, 101:652-658.
131. Karode S.K., Kulkarni S.S., Suresh A.K., Mashelkar R.A. New insights into kinetics and thermodynamics of interfacial polymerization. Chem. Eng. Sci. 1998, 53:2649-6263.
132. Katouzian I., Jafari S.M. Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins. Trends Food Sci. Tech. 2016, 53:34-48.
133. Kawabata Y., Matsumoto M., Tanaka M., Takahashi H., Irinatsu Y., Tagaki W., Nakahara H., Fukuda K. Formation and deposition of monolayers of amphiphilic β-cyclodextrin derivatives. Chem. Lett. 1983, 15:1933-1934.
134. Kfoury M., Auezova L., Greige-Gerges H., Ruellan S., Fourmentin S. Cyclodextrin, an efficient tool for trans-anethole encapsulation: chromatographic, spectroscopic, thermal and structural studies. Food Chem. 2014, 164:454-461.
135. Khoee S., Yaghoobian M. An investigation into the role of surfactants in con-trolling particle size of polymeric nanocapsules containing penicillin-G in doubleemulsion. Eur. J. Med. Chem. 2009, 44:2392-2399.
136. Kim H.S., Sohn B.H., Lee W., Lee J.K., Choi S.J., Kwon S.J. Multifunctional layer-by-layer self-assembly of conducting polymers and magnetic nanoparticles. Thin Solid Films 2002, 419:173-177.
137. Koeda T., Wada Y., Neoh T.L., Wada T., Furuta T., Yoshii H. Encapsulation of retinyl palmitate with a mixture of cyclodextrins and maltodextrins by the kneading method. Food Sci. Technol. Res. 2014, 20:529-535.
138. Koontz J.L., Marcy J.E., O'Keefe S.F., Duncan S.E. Cyclodextrin inclusion complex formation and solid-state characterization of the natural antioxidants alpha-tocopherol and quercetin. J. Agric. Food Chem. 2009, 57:1162-1171.
139. Kostog M., Kohler S., Liebert T., Heinze T. Pure cellulose nanoparticles from trimethylsilyl cellulose. Macromol. Symp. 2010, 294:96-106.
140. Krauland A.H., Alonso M.J. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 2007, 340:134-142.
141. Kreuter J. The mechanism of termination in heterogeneous polymerization. J. Polym. Sci. 1982, 20:543-545.
142. Kwon H.Y., Lee J.Y., Choi S.W., Jang Y., Kim J.H. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloid Surf. A 2001, 182:123-130.
143. Lambert G., Fattal E., Alphandary H.P., Gulik A., Couvreur P. Poly isobutyl cyano acrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. Int. J. Pharm. 2001, 214:13-16.
144. Landfester K., Musyanovych A., Mailander V. From polymeric particles to multifunctional nanocapsules for biomedical applications using the miniemulsion process. J. Polym. Sci. Part A Polym. Chem. 2010, 48:493-515.
145. Laurent S., Bridot J.L., Elst L.V., Muller R.N. Magnetic iron oxide nanoparticles for biomedical applications. Future Med. Chem. 2010, 2:427-449.
146. Lee J.H., Chen K.J., Noh S.H., Garcia M.A., Wang H., Lin W.Y., Jeong H., Kong B.J., Stout D.B., Cheon J., Tseng H.R. On-demand drug release system for in vivo cancer treatment via self assembled magnetic nanoparticles. Angew. Chem. Int. Edit. 2013, 52:4384-4388.
147. Lemoine D., Preat V. Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J. Control. Release 1998, 54:15-27.
148. Lemos-Senna E., 1998. Contribution a l'etude pharmacotechnique et physico-chimique de nanospheres de cyclodextrins amphiphiles comme transporteurs de principes actifs, PhD thesis, Universite Paris-Sud.
149. Lemos-Senna E., Wouessidjewe D., Duchêne D., Lesieur S. Amphiphilic cyclodextrin nanospheres: particle solubilization and reconstitution by the action of a non-ionic detergent. Col. Surf. B: Biointerfaces 1998, 10:291-301.
150. Lemos-Senna E., Wouessidjewe D., Lesieur S., Duchêne D. Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading. Int. J. Pharm. 1998, 170:119-128.
151. Lemos-Senna E., Wouessidjewe D., Lesieur S., Puisieux F., Couarraze G., Duchêne D. Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic nanospheres. Pharm. Dev. Technol. 1998, 3:85-94.
152. Lemos-Senna E., Wouessidjewe D., Lesieur S., Puisieux F., Couarraze G., Duchêne D. Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrins nanospheres. Pharm. Dev. Technol. 1998, 3:1-10.
153. Leroux J.C., Allemann E., Doelker E., Gurny R. New approach for the prepa-ration of nanoparticles by an emulsification-diffusion method. Eur. J. Pharm. Biopharm. 1995, 41:14-18.
154. Li Y., Yang D.J., Chen S.L., Chen S.B., Chan A.S. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm. Res. 2007, 25:563-577.
155. Liu F.Y., Kildsig D.O., Mitra A.K. Complexation of 6-acyl-O-β-cyclodextrin derivatives with steroids, effects of chain length and substitution degree. Drug Dev. Ind. Pharm. 1992, 18:1599-1612.
156. Liu J., Xu R., Kaifer A.E. In situ modification of the surface of gold colloidal particles. Preparation of cyclodextrin-based rotaxanes supported on gold nanospheres. Langmuir 1998, 14:7337-7339.
157. Liu H.K., Lo Y.K., Tsai T.R., Cham T.M. Physicochemical characterizations of osthole hydroxypropyl-β-cyclodextrin inclusion complexes with high-pressure homogenization method. J. Food Drug Anal. 2010, 18:391-397.
158. Locci E., Lai S., Piras A., Marongiu B., Lai A. 13C-CPMAS and 1H-NMR study of the inclusion complexes of β-cyclodextrin with carvacrol, thymol, and eugenol prepared in supercritical carbon dioxide. Chem. Biodivers. 2004, 1:1354-1366.
159. Loftsson T., Duchêne D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 2007, 329:1-11.
160. Loftsson T., Stefansdottir ó., Fridriksdottir H., Gudmundsson ö. Interaction between preservatives and 2-hydroxypropyl-β-cyclodextrin. Drug Devel. Ind. Pharm. 1992, 18:1477-1484.
161. Loftsson T., ólafsdóttir B.J., Fridriksdóttir H., Jónsdóttir S. Cyclodextrin complexation of NSAIDs: physicochemical characteristics. Eur. J. Pharm. Sci. 1993, 1:95-101.
162. Lopedota A., Trapani A., Cutrignelli A., Chiarantini L., Pantucci E., Curci R., Manuali E., Trapani G. The use of Eudragit®RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. Eur. J. Pharm. Biopharm. 2009, 72:509-520.
163. Loukas Y., Antoniadou-Vyza E., Papadaki-Valiraki A., Machera K. Gamma-cyclodextrin inclusion complex of a new organophosphorus insecticide. Determination of stability constant with HPLC. J. Agric. Food Chem. 1994, 42:944-948.
164. Lvov Y., Ariga K., Ichinose I., Kunitake T. Assembly of multicomponent protein films by means of electrostatic layer-by-layer adsorption. J. Am. Chem. Soc. 1995, 117:6117-6123.
165. Madene A., Jacquot M., Scher J., Desobry S. Flavour encapsulation and controlled release-a review. Int. J. Food Sci. Technol. 2006, 41:1-21.
166. Madhulita P., Ganesh P., Amol M., Sunil M., Bhanoji R.M.E. Effect of β-cyclodextrin on physical stability of nimesulide suspension. Int. J. Drug Develop. Res. 2010, 2:669-675.
167. Maestrellia F., Garcia-Fuentes M., Mura P., Alonso M.J. A new drug nanocarrier consisting of chitosan and hydroxypropyl cyclodextrin. Eur. J. Pharm. Biopharm. 2006, 63:79-86.
168. Mahmoud A.A., El-Feky G.S., Kamel R., Awad G.E.A. Chitosan/sulfobuty-lether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int. J. Pharm. 2011, 413:229-236.
169. Makhlof A., Miyazaki Y., Tozuka Y., Takeuchi H. Cyclodextrins as stabilizers for the preparation of drug nanocrystals by the emulsion solvent diffusion method. Int. J. Pharm. 2008, 357:280-285.
170. Marcolino V.A., Zanin G.M., Durrant L.R., Benassi Mde.T., Matioli G. Interaction of curcumin and bixin with β-cyclodextrin: complexation methods, stability, and applications in food. J. Agric. Food Chem. 2011, 59:3348-3357.
171. Marongui, B., Pira, A., Porcedda, S., Delogu, G., Fabbri, D., Dettori, M.A., 2002. In: Besnard, M., Cansell, F. (Eds.), Proceedings of the Eighth Meeting on Supercritical Fluids, Bordeaux, France, p. 327.
172. Masotti A., Bordi F., Ortaggi G., Marino F., Palocci C. A novel method to obtain chitosan/DNA nanospheres and a study of their release properties. Nanotechnology 2008, 19:55302-55307.
173. Maswal M., Dar A.A. Formulation challenges in encapsulation and delivery of citral for improved food quality. Food Hydrocolloid. 2014, 37:182-195.
174. Matsumoto M., Matsuzawa Y., Noguchi S., Sakai H., Abe M. Structure of Langmuir-Blodgett films of amphiphilic cyclodextrin and water-soluble benzophenone. Mol. Cryst. Liq. Cryst. 2004, 425:197-204.
175. Mazzaglia A. Photodynamic tumor therapy with cyclodextrin nanoassemblies. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine 2011, 343-361. John Wiley & Sons, Inc, Hoboken, New Jersey. E. Bilensoy (Ed.).
176. Medeiros S.F., Santos A.M., Fessi H., Elaissari A. Stimuli-responsive magnetic particles for biomedical applications. Int. J. Pharm. 2011, 403:139-161.
177. Medeiros S.F., Lara B.R., Oliveira P.F.M., Moraes R.M., Alves G.M., Elaissari A., Santos A.M. Stimuli-responsive and biocompatible poly(N-vinylcapro-lactam-co-acrylic acid)-coated iron oxide nanoparticles by nanoprecipitation technique. J. Colloid Sci. Biotechnol. 2013, 2:180-194.
178. Memişoğlu E., Bochot A., özalp M., Sen M., Duchêne D., Hincal A.A. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm. Res. 2002, 20:117-125.
179. Memişoğlu E., Bochot A., Sen M., Charon D., Duchêne D., Hincal A.A. Amphiphilic β-cyclodextrins modified on the primary face: synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules. J. Pharm. Sci. 2002, 91:1214-1224.
180. Memişoğlu E., Bochot A., Sen M., Duchêne D., Hincal A.A. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm. Res. 2003, 20:117-125.
181. Memioşğlu E., Bochot A., Sen M., Duchêne D., Hincal A.A. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins. Int. J. Pharm. 2003, 251:143-153.
182. Memisoglu-Bilensoy E., Hincal A.A. Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving. Int. J. Pharm. 2006, 311:203-208.
183. Memisoglu-Bilensoy E., Vural I., Bochot A., Rendir J.-M., Duchêne D., Hincal A.A. Tamoxifen citrate loaded amphiphilic cyclodextrin nanoaprticles: In Vitro characterization and cytotoxicity. J. Control. Release 2005, 104:489-496.
184. Memisoglu-Bilensoy E., Ďgan A.L., Hincal A.A. Cytotoxic evaluation of injectable cyclodextrin nanoparticles: surfactant effect. J Pharm. Pharmacol. 2006, 58:585-589.
185. Memisoglu-Bilensoy E., Sen M., Hincal A.A. Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules. J. Microencapsul. 2006, 23:59-68.
186. Memisoglu-Bilensoy E., Trichard L., Bochot A., Duchêne D., Hincal A.A. Amphiphilic cyclodextrins and microencapsulation. Microencapsulation-Methods and Industrial Applications 2006, 269-296. Taylor & Francis Ltd, New York. S. Benita (Ed.).
187. Méndez-Ardoy A., Urbiola K., Aranda C., Ortiz-Mellet C., García-Fernández J.M., de Ilarduya C.T. Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery. Nanomedicine (Lond.) 2011, 6:1697-1707.
188. Menezes P.P., Araújo A.A.S., Dória G.A.A., Quintans-Júnior L.J., Oliveira M.G.B., Santos M.R.V., Oliveira J.F., Matos J.R., Carvalho F.M.S., Alves P.B., Matos I.L., Santos D.A., Marreto R.N., Silva G.F., Serafini M.R. Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. poit leaves with β-cyclodextrin. Curr. Pharm. Biotechnol. 2015, 16:1-11.
189. Messner M., Kurkov S.V., Jansook P., Loftsson T. Self-assembled cyclodextrin aggregates and nanoparticles. Int. J. Pharmaceut. 2010, 387:199-208.
190. Mielcarek J. Photochemical stability of the inclusion complexes of nicardipine with α-, β-cyclodextrin, methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin in solid state and in solution. Pharmazie 1996, 51:477-479.
191. Miladi K., Sfar S., Fessi H., Elaissari A. Drug carriers in osteoporosis: preparation, drug encapsulation and applications. Int. J. Pharm. 2013, 445:181-195.
192. Montasser I., Briançon S.I., Fessi H. The effect of monomers on the formulation of polymeric nanocapsules based on polyureas and polyamides. Int. J. Pharm. 2007, 335:176-179.
193. Monza da Silveira A., Ponchel G., Puisieux F., Duchêne D. Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm. Res. 1998, 15:1051-1055.
194. Monza da Silveira, A., Ponchel, G., Duchene, D., Couvreur, P., Puisieux, F., 1999. Nanoparticles comprising polyisobutylcyanoacrylate and cuclodextrins. France, WO 99/43359.
195. Mora-Huertas C.E., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010, 385:113-142.
196. Muhrer G., Meier V., Fusaro F., Albano S., Mazzotti M. Use of compressed gas precipitation to enhance the dissolution behaviour of a poorly water-soluble drug: generation of drug microparticles and drug polymer solid dispersions. Int. J. Pharm. 2006, 308:69-83.
197. Mulay M.S. Taste masking by inclusion complexation: a review. Int. J. Pharm. Res. Dev. 2011, 3:35-47.
198. Müller B.W., Brauns U. Hydroxypropyl-β-cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity. J. Pharm. Sci. 1986, 75:571-572.
199. Munin A., Edwards-Lévy F. Encapsulation of natural polyphenolic compounds: a review. Pharmaceutics 2011, 3:793-829.
200. Mura P., Fauci M.T., Parrini P.L., Furlanetto S., Pinzauti S. Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. Int. J. Pharm. 1999, 179:117-128.
201. Mura P., Maestrelli F., Cecchi M., Bragagni M., Almeida A. Development of anew delivery system consisting in "drug-in cyclodextrin-in PLGA nanoparticles". J. Microencapsul. 2010, 27:479-486.
202. Murakami H., Kobayashi M., Takeuchi H., kawashima Y. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm. 1999, 178:143-152.
203. Nacsa á., Ambrus R., Berkesi O., Szabó-Révész P., Aigner Z. Water-soluble loratadine inclusion complex: analytical control of the preparation by microwave irradiation. J. Pharm. Biomed. Anal. 2008, 48:1020-1023.
204. Nagavarma B.V.N., Yadav H.K.S., Ayaz A., Vasudha L.S., Shivakumar H.G. Different techniques for preparation of polymeric nanoparticles-a review. Asian J. Pharm. Clin. Res. 2012, 5:16-23.
205. Nahaei M., Valizadeh H., Baradaran B., Nahaei M.R., Asgari D., Hallaj-Nezhadi S., Dastmalchi S., Lotfipour F. Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encodinginterleukin-12. Drug Res. 2013, 63:7-12.
206. Nakai Y., Yamamoto K., Terada K., Watanabe D. New methods for preparing cyclodextrin inclusion compounds. I. Heating in a sealed container. Chem. Pharm. Bull. 1987, 35:4609-4615.
207. Nalage S.V., Bhosale, Sidhanath V., Sheshanath V., Bhosale R.S. Kanamycin A-gold nanoparticles: a receptor for cation, anion and neutral species. J. Colloid Sci. Biotechnol. 2013, 2:195-199.
208. Nasir A., Harikumar S.L., Kaur A. Cyclodextrins: an excipients tool in drug delivery. Int. Res. J. Pharma. 2012, 3:44-50.
209. Nasir A., Kausar A., Younus A. A review on preparation, properties and applications of polymeric nanoparticle-based materials. Polym. Plast. Technol. Eng. 2015, 54:325-341.
210. Nerome H., Machmudah S., Wahyudiono, Fukuzato R., Higashiura T., Youn Y.S., Lee Y.W., Goto M. Nanoparticle formation of lycopene/β-cyclodextrin inclusion complex using supercritical antisolvent precipitation. J. Supercrit. Fluid. 2013, 83:97-103.
211. Nowicki A., Zhang Y., Léger B., Rolland J.P., Bricout H., Monflier E., Roucoux A. Supramolecular shuttle and protective agent: a multiple role of methylated cyclodextrins in the chemoselective hydrogenation of benzenederivatives with ruthenium nanoparticles. Chem. Commun. 2006, 45:296-298.
212. O'Donnell P.B., McGinity J.W. Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev. 1997, 28:25-42.
213. Ortiz Mellet C., García-Fernández J.M., Benito J.M. Cyclodextrin-based gene delivery systems. Chem. Soc. Rev. 2011, 40:1586-1608.
214. Ozyilmaz E., Sayin S., Arslan M., Yilmaz M. Improving catalytic hydrolysis reaction efficiency of sol-gel-encapsulated Candida rugosa lipase with magnetic β-cyclodextrin nanoparticles. Colloid. Surf. B: Biointerfaces 2014, 113:182-189.
215. Pagington J.S. β-cyclodextrin: the success of molecular inclusion. Chem. Br. 1987, 23:455.
216. Parikh R.K., Mansuri N.S., Gohel M.C., Sonlwala M.M. Dissolution enhancement of nimesulide using complexation and salt formation techniques. Indian Drug. 2005, 42:149-153.
217. Parlati S., Gobetto R., Barolo C., Arrais A., Buscaino R., Medana C., Savarino P. Preparation and application of a β-cyclodextrin-disperse/reactive dye complex. J. Incl. Phenom. Macrocycl. Chem. 2007, 57:463-470.
218. Patel R., Patel M., Shah D. Applications of cyclodextrin in drug delivery. Int. J. Pharma. World. Res. 2010, 1:1-22.
219. Patil J.S., Kadam D.V., Marapur S.C., Kamalapur M.V. Inclusion complex system; a novel technique to improve the solubility and bioavailability of poorly soluble drugs. Int. J. Pharm. Sci. 2010, 2:29-32.
220. Peltonen L., Valo H., Kolakovic R., Laaksonen T., Hirvonen J. Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles. Expert Opin. Drug Deliv. 2010, 7:705-719.
221. Perdersen N.R., Kristensen J.B., Bauw G., Ravoo B.J., Darcy R., Larsen K.L., Pedersen L.H. Thermolysin catalyses the synthesis of cyclodextrin esters in DMSO. Tetrahedron Asymm. 2005, 16:615-622.
222. Péroche S., Degobert G., Putaux J.L., Blanchin M.G., Fessi H., Parrot-Lopez H. Synthesis and characterization of novel nanospheres made from amphiphilic perfluoroalkylthio-β-cyclodextrins. Eur. J. Pharm. Biopharm. 2005, 60:123-131.
223. Perrut M., Jung J., Leboeuf F. Enhancement of dissolution rate of polysoluble active ingredients by supercritical fluid processes. Part I: micronization of neat particles. Int. J. Pharm. 2005, 288:3-10.
224. Pinto Reis C., Neufeld R.J., Ribeiro A.J., Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed: Nanotechnol. Biol. Med. 2006, 2:8-21.
225. Pitha J., Hoshino T. Effects of ethanol on formation of inclusion complexes of hydroxypropyl cyclodextrins with testosterone or with methyl organe. Int. J. Pharm. 1992, 80:243-251.
226. Puglisi G., Fresta M., Giammona G., Ventura C.A. Influence of the preparation conditions in poly(ethylcyanoacrylate) nanocapsule formation. Int. J. Pharm. 1995, 125:283-287.
227. Puig J.E. Microemulsion polymerization (oil-in-water). Polymeric Materials Encyclopedia 1996, 4333-4341. CRC Press, Boca Raton, FL. J.C. Salamone (Ed.).
228. Qi Z.H., Hedges A.R. Use of cyclodextrins for flavors. Flavor Technology: Physical Chemistry, Modification and Process 1995, 231-243. Washington DC, American Chemical Society, USA. C.T. Ho, C.H. Tong (Eds.).
229. Quintanar-Guerrero D., Zambrano-Zaragoza M.L., Gutierrez-Cortez E., Mendoza-Munoz N. Impact of the emulsification-diffusion method on the development of pharmaceutical nanoparticles. Recent Pat. Drug Deliv. Formul. 2012, 6:184-194.
230. Rahman M.M., Elaissari A. Organic-inorganic hybrid magnetic latex. Hybrid Latex Particles Advances in Polymer Science 2010, 237-281. Springer, Berlin, Heidelberg. A.M. Herk, K. van Landfester (Eds.).
231. Rahman M.M., Elaissari A. Multi-stimuli responsive magnetic core-shell particles: synthesis, characterization and specific RNA recognition. J. Colloid Sci. Biotechnol. 2012, 1:3-15.
232. Rajabi H., Ghorbani M., Jafari S.M., Sadeghi Mahoonak A., Rajabzadeh G. Retention of saffron bioactive components by spray drying encapsulation using maltodextrin, gum Arabic and gelatin as wall materials. Food Hydrocoll. 2015, 51:327-337.
233. Rao J.P., Geckeler K.E. Polymer nanoparticles: preparation techniques and size-control parameters. Prog. Polym. Sci. 2011, 36:887-913.
234. Rekharsky M.V., Inoue Y. Complexation thermodynamics of cyclodextrins. Chem. Rev. 1998, 98:1875-1918.
235. Ribeiro L.S.S., Ferreira D.C., Veiga F.J.B. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur. J. Pharm. Sci. 2003, 20:253-266.
236. Ribeiro A., Figueiras A., Santos D., Veiga F. Preparation and solid state characterization on inclusion complexes formed between miconazole and methyl-β-cyclodextrin. AAPS Pharm. Sci. Technol. 2008, 9:1102-1109.
237. Rimmer S. Cyclodextrins in the emulsion polymerization of vinyl monomers. Macromol. Symp. 2000, 150:149-154.
238. Ringard-Lefebvre C., Bochot A., Memisoglu E., Charon D., Duchêne D., Baszkin A. Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system. Coll. Surf. B Biointerf. 2002, 25:109-117.
239. Rotureau E., Raynaud J., Choquenet B., Marie E., Nouvel C., Six J.L., Dellacherie E., Durand A. Application of amphiphilic polysaccharides as stabilizers in direct and inverse free-radical miniemulsion polymerization. Colloid. Surf. Physicochem. Eng. Asp. 2008, 331:84-90.
240. Roux M., Auzély-Velty R., Djedaini-Pilard F., Perly B. Cyclodextrin-induced lipid lateral separation in DMPC membranes: (2)H nuclear magnetic resonance study. Biophys. J. 2002, 82:813-822.
241. Saenger W., Noltemeyer M., Manor P.C., Hingerty B., Klar B. Induced-fit type complex formation of the model enzyme β-cyclodextrin. Bioorg. Chem. 1976, 5:187-195.
242. Sah H. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres. J. Control. Release 1997, 47:233-245.
243. Saharan V.A., Kukkar V., Kataria M., Gera M., Choudhary P.K. Dissolution enhancement of drugs. Part I: technologies and effect of carriers. Int. J. Health. Res. 2009, 2:107-124.
244. Sahu S., Mohapatra S. Multifunctional magnetic fluorescent hybrid nanoparticles as carriers for the hydrophobic anticancer drug 5-fluorouracil. Dalton Trans. 2013, 42:2224-2231.
245. Sajeesh S., Sharma C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 2006, 325:147-154.
246. Sani S.N., Das N.G., Das S.K. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization. J. Microencapsul. 2009, 26:556-561.
247. Sapkal N.P., Kilor V.A., Bhusari K.P., Daud A.S. Evaluation of some methods for preparing gliclazide beta-cyclodextrin inclusion complexes. Trop. J. Pharm. Res. 2007, 6:833-840.
248. Saravana K.K., Sushma M., Prasanna R.Y. Dissolution enhancement of poorly soluble drugs by using complexation technique-a review. J. Pharm. Sci. Res. 2013, 5:120-124.
249. Sarkar D., El Khoury J., Lopina S.T., Hu J. An effective method for preparing polymer nanocapsules with hydrophobic acrylic shell and hydrophilic interior by inverse emulsion radical polymerization. Macromolecul. 2005, 38:8603-8605.
250. Schubert R. Liposome preparation by detergent removal. Method Enzymol. 2003, 367:46-70.
251. Schwinte P., Ramphul M., Darcy R., O'Sullivan J.F. Amphiphilic cyclodextrin complexation of clofazimine. J. Incl. Phenom. Macrocyclic Chem. 2003, 47:109-112.
252. Scott C., Wu D., Ho C.C., Co C.C. Liquid-core capsules via interfacial polymerization: a free-radical analogy of the nylon rope trick. J. Am. Chem. Soc. 2005, 127:4160-4161.
253. Semalty A. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis. Exp. Opin. Drug Deliv. 2014, 11:1255-1272.
254. Semalty A., Tanwar Y.S., Semalty M. Preparation and characterization of cyclodextrin inclusion complex of naringenin and critical comparison with phospholipid complexation for improving solubility and dissolution. J. Thermal Anal. Calorim. 2014, 115:2471-2478.
255. Semalty M., Panchpuri M., Singh D., Ajay R. Cyclodextrin inclusion complex of racecadotril: effect of drug-beta-cyclodextrin ratio and the method of complexation. Curr. Drug Discov. Tech. 2014, 11:154-161.
256. Seo S., Khang G., Rhee J., Kim J., Lee H. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres. J. Microencapsul. 2003, 20:569-579.
257. Shapiro Y.E. Nanoencapsulation of bioactive substances. Dekker Encyclopedia of Nanoscience and Nanotechnology 2004, 2339-2352. Marcel Dekker, New York, USA. J.A. Schwarz, C.I. Contescu, K. Putyera (Eds.).
258. Shiga H., Yoshii H., Ohe H., Yasuda M., Furuta T., Kuwahara H., Ohkawara M., Linko P. Encapsulation of Shiitake (Lenthinus edodes) flavors by spray drying. Biosci. Biotechnol. Biochem. 2004, 68:66-71.
259. Shimpi S., Chauhan B., Shimpi P. Cyclodextrins: application in different routes of drug administration. Acta Pharm. 2005, 55:139-156.
260. Shin-ichi Y., Katsuhiro I., Keiichi M., Hideo T., Akira O. Evaluation of ophthalmic suspensions using surface tension. Eur. J. Pharm. Biopharm. 2004, 57:377-382.
261. Shu S., Wang X., Zhang X., Zhang X., Wang Z., Li C. Disulfide cross-linked biodegradable polyelectrolyte nanoparticles for the oral delivery of protein drugs. New J. Chem. 2009, 33:1882-1887.
262. Shu S., Zhang X., Wu Z., Wang Z., Li C. Gradient cross-linked biodegradable polyelectrolyte nanocapsules for intracellular protein drug delivery. Biomaterials 2010, 31:6039-6049.
263. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 2009, 61:467-477.
264. Silveira M.A., Ponchel G., Puisieux F., Duchêne D. Combined poly (isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm. Res. 1998, 15:1051-1055.
265. Singh R., Bharti N., Madan J., Hiremath S.N. Characterization of cyclodextrin inclusion complexes-a review. J. Pharm. Sci. Technol. 2010, 2:171-183.
266. Skiba, M., Wouessidjewe, D., Fessi, H., Devissaguet, J.P., Duchêne, D., Puisieux, F., 1992. Preparation et utilizations des nouveau systemes colloidaux dispersibles a base de cyclodextrines sous forme de nanocapsules. French Patent, 9207285.
267. Skiba M., Morvan C., Duchêne D., Puisieux F. Evaluation of the gastrointestinal behaviour in the rat of amphiphilic β-cyclodextrin nanocapsules loaded with indomethacin. Int. J. Pharm. 1995, 126:275-279.
268. Skiba M., Duchêne D., Puisieux F., Wouessidjewe D. Development of a new colloidal drug carrier from chemically modified cyclodextrins: nanospheres and influence of physicochemical and technological factors on particle size. Int. J. Pharm. 1996, 129:113-121.
269. Skiba M., Nemati F., Puisieux F., Duchêne D., Wouessidjewe D. Spontaneous formation of drug-containing amphiphilic cyclodextrin nanocapsules. Int. J. Pharm. 1996, 145:241-245.
270. Skiba M., Bounoure F., Barbot C., Arnaud P., Skiba M. Development ofcyclodextrin microspheres for pulmonary drug delivery. J. Pharm. Pharmaceut. Sci. 2005, 8:409-418.
271. Song L.X., Bai L., Xu X.M., He J., Pan S.Z. Inclusion complexation, encapsulation interaction and inclusion number in cyclodextrin chemistry. Coordin. Chem. Rev. 2009, 253:1276-1284.
272. Steckel H., Wehle S. A novel formulation technique for metered dose inhaler (MDI) suspensions. Int. J. Pharm. 2004, 284:75-82.
273. Sukegawa T., Furuike T., Niikura K., Yamagishi A., Nishimura S.I. Erythrocyte-like liposomes prepared by means of amphiphilic cyclodextrin sulfates. Chem. Commun. 2002, 5:430-431.
274. Sun S., Zeng H. Size-controlled synthesis of magnetite nanoparticles. J. Am. Chem. Soc. 2002, 124:8204-8205.
275. Szejtli J. Topics in inclusion science-cyclodextrin technology. Cyclodextrin Technology 1988, Kluwer Academic Publisher, Dordrecht, Netherlands. J.E.D. Davies (Ed.).
276. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 1998, 98:1743-1753.
277. Szejtli J. Past, present, and future of cyclodextrin research. Pure Appl. Chem. 2004, 76:1825-1845.
278. Szejtli J., Cserhati T., Szögyi M. Interactions between cyclodextrins and cell-membrane phospholipids. Carbohydr. Polym. 1986, 6:35-49.
279. Tapas A.R., Kawtikwar P.S., Sakarkar D.M. Evaluation of physico-mechanical properties of carvedilol-cyclodextrin agglomerates obtained by emulsion solvent diffusion method. Lat. Am. J. Pharm. 2011, 30:1461-1467.
280. Teijeiro-Osorio D., Remunán-López C., Alonso M.J. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur. J. Pharm. Biopharm. 2009, 71:257-263.
281. Tirucherai G.S., Mitra A.K. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovier. AAPS Pharm. Sci. Technol. 2003, 4:E45.
282. Torini L., Argillier J.F., Zydowicz N. Interfacial polycondensation encapsulation in miniemulsion. Macromolecul. 2005, 38:3225-3236.
283. Torres-Labandeira J.J., Davignon P., Pitha J. Oversaturated solutions of drug in hydroxypropylcyclodextrins: parenteral preparation of pancratistatin. J. Pharm. Sci. 1990, 80:384-386.
284. Trapani A., Garcia-Fuentes M., Alonso M.J. Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan. Nanotechnology 2008, 19:185101.
285. Tsinontides S.C., Rajnaik P., Pham D., Hunke W.A., Placek J., Reynolds S.D. Freeze drying-principles and practice for successful scale up to manufacturing. Int. J. Pharm. 2004, 28:1-16.
286. Tsorteki F., Bethanis K., Pinotsis N., Giastas P., Mentzafos D. Structure of the inclusion complexes of heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin withindole-3-butyric acid and 2,4-dichlorophenoxyacetic acid. Carbohydr. Res. 2004, 339:233-240.
287. Udagama R., Degrandi-Contraires E., Creton C., Graillat C., McKenna T.F.L., Bourgeat-Lami E. Synthesis of polymer-polymer hybrids by miniemulsion polymerization and characterization of hybrid latex. Macromolecul. 2011, 44:2632-2642.
288. Uekama K., Hirayama F., Irie T. Cyclodextrin drug carrier systems. Chem. Rev. 1998, 98:2045-2076.
289. US Federal Register, 2005. Alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin: exemption from the requirement of a tolerance. US Federal Register 70, 38780-38785.
290. Van Hees T., Piel G., Evrard B., Otte X., Thunus L., Delattre L. Application of supercritical carbon dioxide for the preparation of piroxicam-β-cyclodextrin inclusion compound. Pharm. Res. 1999, 16:1864-1870.
291. Van Herk A.M. Modeling of emulsion copolymerizations will it ever be possible? Part III conclusion. J. Colloid Sci. Biotechnol. 2012, 1:169-174.
292. Vauthier C., Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharmaceut. Res. 2008, 26:1025-1058.
293. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 2003, 55:519-548.
294. 3 ultrafine powders by laser pyrolysis. Mater. Lett. 1998, 35:227-231.
295. Vila A., Sanchez A., Tobio M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Control. Release 2002, 78:15-24.
296. Villiers A. Sur la fermentation de la fe cule par l'action du ferment butyrique. C. R. Acad. Sci. 1891, 112:536-538.
297. Vitale S.A., Katz J.L. Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation: the ouzo effect. Langmuir 2003, 19:4105-4110.
298. Vozone C.M., Marques H.M.C. Complexation of budesonide in cyclodextrins and particle aerodynamic characterization of the complex solid form for dry powder inhalation. J. Incl. Phenom. Macroc. Chem. 2003, 44:111-115.
299. Waalkens-Berendsen D.H., Smits van Prooije A.E., Bar A. Embryotoxicity and teratogenicity study with β-cyclodextrin in rabbits. Regul. Toxicol. Pharmacol. 1998, 27:172-177.
300. Waleczek K.J., Cabral Marques H.M., Hempel B., Schmidt P.C. Phase solubility studies of pure (-)-α-bisabolol and camomile essential oil with β-cyclodextrin. Eur. J. Pharm. Biopharm. 2003, 55:247-251.
301. 2. J. Haz. Mat. 2011, 191:163-169.
302. Wang Q.F., Fan X.W., Xu L., Yao Y. Preparation of inclusion complex of paeonol and beta-cyclodextrin by sealed-control temperature method. Chin. J. Chin. Mater. Med. 2007, 32:218-221.
303. Watnasirichaikul S., Davies N.M., Rades T., Tucker I.G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm. Res. 2000, 17:684-689.
304. Wenz G. Synthesis and characterization of some lipophilic per (2,6-di-O-alkyl) cyclomaltooligosaccharides. Carbohydr. Res. 1991, 214:257-265.
305. Wenz G., Thomas H. Synthesis of highly water-soluble cyclodextrin sulfonates by addition of hydrogen sulfite to cyclodextrin allyl ethers. Carbohydr Res. 1999, 322:153-165.
306. Wongmekiat A., Tozuka Y., Moribe K., Oguchi T., Yamamoto K. Preparation of drug nanoparticles by co-grinding with cyclodextrin: formation mechanism and factors affecting nanoparticle formation. Chem. Pharm. Bull. 2007, 55:359-363.
307. Wouessidjewe D., Skiba M., Leroy-Lechat F., Lemos-Senna E., Puisieux F., Duchêne D. A new concept in drug delivery based on 'skirt-shaped cyclodextrins aggregates' present state and future prospects. STP Pharma. Sci. 1996, 6:21-26.
308. Wouessidjewe D., Skiba M., Leroy-Lechat F., Lemos-Senna E., Puisieux F., Duchêne D. A new concept in drug delivery based on skirt-shaped cyclodextrin aggregates, present state and future prospects. STP Pharma. Sci. 1996, 6:21-28.
309. Wu W., He Q., Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res. Lett. 2008, 3:397-415.
310. Wu M., Dellacherie E., Durand A., Marie E. Poly(n-butyl cyanoacrylate)nanoparticles via miniemulsion polymerization (1): dextran-based surfactants. Colloid. Surf. B Biointerfaces 2009, 69:141-146.
311. Wu M., Dellacheriea E., Durand A., Marie E. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. PEG-based surfactants. Colloid. Surf. B 2009, 69:147-151.
312. Wulff M., Aldén M. Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur. J. Pharm. Sci. 1999, 8:269-281.
313. Xia H.B., Yi J., Foo P.-S., Liu B. Facile fabrication of water-soluble magnetic nanoparticles and their spherical aggregates. Chem. Mater. 2007, 19:4087-4091.
314. Xia Y., Li W., Cobley C.M., Chen J., Xia X., Zhang Q., Yang M., Cho E.C., Brown P.K. Gold nanocages: from synthesis to theranostic applications. Acc. Chem. Res. 2011, 44:914-924.
315. Xie J., Wang C. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Pharm. Res. 2005, 22:2079-2090.
316. Yallapu M.M., Othman S.F., Curtis E.T., Bauer N.A., Chauhan N., Kumar D., Jaggi M., Chauhan S.C. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int. J. Nanomed. 2012, 7:1761-1779.
317. Yang C., Castelvetro V., Scalarone D., Bianchi S., Zhang Y. Three different β-cyclodextrins direct the emulsion copolymerization of a highly fluorinated methacrylate toward distinctive nanostructured particle morphologies. J. Polym. Sci. Polym. Chem. 2011, 49:4518-4530.
318. Yano H., Kleinebudde P. Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: comparison between melt extrusion and wet extrusion. AAPS. Pharm. Sci. Tech. 2010, 11:885-893.
319. Yildiz U., Landfester K. Miniemulsion polymerization of styrene in the presence of macromonomeric initiators. Polymer 2008, 49:4930-4934.
320. Yoshii H., Yasuda M., Furuta T., Kuwahara H., Ohkawara M., Linko P. Retention of cyclodextrin complexed shiitake (Lentinus edodes) flavors with spray drying. Drying Technol. 2005, 23:1205-1215.
321. Yousaf A.M., Kim D.W., Oh Y.K., Yong C.S., Kim J.O., Choi H.G. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Int. J. Nanomed. 2015, 10:1819-1830.
322. Yuan Z., Ye Y., Gao F., Yuan H., Lan M., Lou K., Wang W. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Int. J. Pharm. 2013, 446:191-198.
323. Yuliani S., Torley P.J., D'Arcy B., Nicholson T., Bhandari B. Extrusion of mixtures of starch and d-limonene encapsulated with β-cyclodextrin: flavor retention and physical properties. Food Res. Int. 2006, 39:318-331.
324. Zhang J., Ma P.X. Host-guest interaction mediated polymeric core-shell assemblies: versatile nanocarriers for drug delivery. Angew. Chem. Int. Ed. Engl. 2009, 48:964-968.
325. Zhang J., Ma P.X. Core-shell structured nanoassemblies based on β-cyclodextrin containing block copolymer and poly(β-benzyl l-aspartate) viahost-guest complexation. Polymer (Guildf.) 2011, 52:4928-4937.
326. Zhang P., Ling C.C., Coleman A.W., Parrot-Lopez H., Galons H. Formation of amphiphilic cyclodextrin via hydrophobic esterification at the secondary hydroxyl face. Tetrahedron Lett. 1991, 32:2769-2770.
327. Zhang P., Parrot-Lopez H., Tchoreloff P., Basakin A., Ling C.C., De Rango C., Coleman A.W. Self-organizing systems based on amphiphilic cyclodextrins diesters. J. Phys. Org. Chem. 1992, 5:518-528.
328. Zhou J., Ritter H. Cyclodextrin functionalized polymers as drug delivery systems. Polym. Chem. 2010, 1:1552-1559.
329. Zhou R., Wang F., Guo Z., Zhao Y.L. Preparation and characterization of resveratrol/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent technology. J. Food Process Eng. 2012, 35:677-686.
330. Zhu J., He J., Du X., Lu R., Huang L., Ge X. A facile and flexible process of β-cyclodextrin grafted on Fe3O4 magnetic nanoparticles and host-guest inclusion studies. Appl. Surf. Sci. 2011, 257:9056-9062.
331. Zia V., Rajewski R., Bornancini E.R., Luna E.A., Stella V.J. Effect of alkyl chain length and substitution degree on the complexation of sulfoalkyl ether β-cyclodextrins with steroids. J. Pharm. Sci. 1997, 86:220-224.
332. Ziegler A., Landfester K., Musyanovych A. Synthesis of phosphonate functionalized polystyrene and poly(methyl methacrylate) particles and their kinetic behavior in miniemulsion polymerization. Colloid. Polym. Sci. 2009, 287:1261-1271.